REPLY S.p.A.: Shareholders’ Meeting Approves the 2017 Financial Statements
- Consolidated turnover of €884.4 million (+13.3%);
- Group net profits of €77.9 million (+ 15.3%).
The proposal to distribute a dividend of €0.35 per share has been approved.
The Board of Directors and the Board of Statutory Auditors have been appointed for the three-year period 2018-2020.
Resolutions in relation to the purchase and/or sale of own shares.
Reply S.p.A. Shareholders’ meeting [MTA, STAR: REY] today approved the Financial Statements for the financial year 2017, confirming the distribution of a gross dividend of €0.35 per share (up 21.7% compared to the previous year, taking into consideration the equity split occurred in October 2017, which converted each ordinary share, having a nominal value of €0.52 into 4 new ordinary shares, nominal value of €0.13).
The dividend will be paid on 9 May 2018, with dividend detachment date set on 7 May 2018 and record date 8 May 2018.
Financial Statements of the 2017 financial year
The Reply Group closed the 2017 financial year with a consolidated turnover of €884.4 million, increasing by 13.3% compared to the €780.7 million turnover of 2016. EBITDA amounted to €123.2 million (€106.4 million in 2016), while EBIT amounted to €113.9 million (€99.6 million in 2016).
The group net profit amounted to €77.9 million, an increase of 15.3% compared to the €67.5 million net profit recorded in 2016.
The Shareholders’ Meeting also approved the following resolutions:
Appointment of the Board of Directors and the Board of Statutory Auditors for the next three years
The Shareholders’ Meeting appointed the new members of the Board of Directors and the Board of Statutory Auditors for the three-year period 2018-2020, on the basis of the lists of candidates presented.
Appointed Directors were:
- Mario Rizzante (Chairman), Tatiana Rizzante, Filippo Rizzante, Daniele Angelucci, Claudio Bombonato, Elena Previtera and Fausto Forti, taken from the majority slate presented by the shareholder Alika S.r.l. (holder of a 45.1% stake in Reply S.p.A.), which obtained the highest number of votes (61.19 % of votes obtained).
- Secondina Giulia Ravera and Francesco Umile Chiappetta, taken from the minority slate submitted by a group of investors (holders of a total stake of 1.744% of the share capital of Reply S.p.A.)
The nominated Board of Statutory Auditors consists of three members and two alternates:
- Giorgio Mosci (Chairman) and Giancarla Branda (Alternate Auditor), taken from the minority slate presented by a group of Investors (holding a total stake of 1.744% of the share capital of Reply S.p.A.)
- Piergiorgio Re (effective), Ada Alessandra Garzino Demo (effective), Stefano Barletta (alternate), taken from the majority slate presented by the shareholder Alika S.r.l. (holder of a 45.1% stake in Reply S.p.A.), which obtained the highest number of votes (65,10 % of votes obtained).
The CV of the Directors and Statutory Auditors and the additional documentation required by current legislation are available in the investors section of the website www.reply.com
Resolutions in relation to the purchase and sale of own shares
The Shareholders ‘Meeting authorised a new programme for the purchase of treasury shares, withdrawing the one currently approved in the Shareholders’ Meeting of 21 April 2017: the main objective of this programme is the purchase of shares to service the stock incentive plans, transactions aimed at the acquisition of investments, extraordinary financial transactions and/or the conclusion of agreements with strategic partners.
The authorisation has a duration of 18 months from the date of the resolution, for a maximum of 7,478,256 ordinary shares (equal to 19.9892% of the current share capital) with a nominal value of €0.13 each for a maximum nominal value of €972,173.28, within the limit of a maximum financial commitment of €100,000,000. The purchase price cannot be lower than the nominal value (currently €0.13) and higher than the official price of the trades registered on the MTA market the day before the purchase increased by 15%.
Approval of the Remuneration Report
The Shareholders’ Meeting also approved Section I of the Remuneration Report prepared pursuant to Art. 123-ter of the Legislative Decree. No. 58/1998
The manager responsible for preparing the company's financial reports, Dr Giuseppe Veneziano, states in accordance with Paragraph 2 of Article 154-bis of the Consolidated Finance Act, that the accounting information contained in this press release corresponds to the company's records, ledgers and accounting entries.
Reply [MTA, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. Reply is a network of highly specialised companies supporting key European industrial groups operating in the telecom and media, industry and services, banking, insurance and public administration sectors in the definition and development of business models enabled for the new paradigms of big data, cloud computing, digital media and the Internet of Things. Reply services include: Consulting, System Integration and Digital Services. www.reply.com
This press release is a translation, the Italian version will prevail.
Investor Relation Contacts
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Schlumberger Announces Fourth-Quarter and Full-Year 2018 Results Conference Call16.11.2018 21:00 | Tiedote
Schlumberger Limited (NYSE:SLB) will hold a conference call on January 18, 2019 to discuss the results for the fourth quarter and full year ending December 31, 2018. The conference call is scheduled to begin at 8:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 288-8967 within North America or +1 (612) 333-4911 outside of North America approximately 10 minutes prior to the start of the call, and ask for the “Schlumberger Earnings Conference Call.” A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until February 18, 2019, and can be accessed by dialing +1 (800)
Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 17:33 | Tiedote
Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W
Guidewire Enhances PartnerConnect Consulting Program with Addition of Product and Regional Specializations16.11.2018 16:55 | Tiedote
Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced the addition of specializations to its PartnerConnect Consulting program. Specializations have been added to aid insurance companies in selecting the best partner to lead or staff their Guidewire projects. Guidewire unveiled new specializations, including two which have been successfully piloted earlier this year. “Our customers will now have more clarity and information as to which partners have the proven capabilities in their chosen product and region,” said Lisa Walsh, vice president, Alliances, Guidewire Software. “Adding these specializations will also allow us to have more insight into a partner’s performance and competencies.” To earn a specialization, partners need to demonstrate skills, knowledge, and competency in a specific Guidewire product or solution by certifying staff at multiple levels (specialist and professional) through Guidewire’
Janssen receives positive CHMP opinion for ERLEADA™ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease16.11.2018 16:15 | Tiedote
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for apalutamide, a next generation oral androgen receptor inhibitor for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.2 The CHMP’s positive opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the use of apalutamide. The CHMP’s positive opinion is based on data from the pivotal SPARTAN Phase 3 clinical study which assessed the safety and efficacy of apalutamide versus placebo in patients with nmCRPC who have a rapidly rising prostate specific antigen (PSA) level despite receiving continuous androgen deprivation therapy (ADT). The SPARTAN clinical study showed that apalutamide, when added to ADT, significantly reduced the risk
Vertex Receives European CHMP Positive Opinion for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease16.11.2018 15:57 | Tiedote
Vertex Pharmaceuticals (Europe) Limited today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, lumacaftor/ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF for patients aged 2 to 5 years old who have two copies of the F508del mutation. “Cystic fibrosis is a chronic, progressive disease and it is important to treat early to ensure the best possible outcomes for patients,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. “Today’s announcement brings us one step cl
Dimension Data Global Delivery Centre (GDC) in Prague wins the ABSL 2018 Diamond Award for Business Innovation16.11.2018 11:00 | Tiedote
Dimension Data, the USD 8 billion global technology integrator and managed services provider, today announced that its Global Delivery Centre (GDC) in Prague has won the 2018 ABSL Diamond award for Business Innovation. The main purpose of this centre is to provide innovative, global service delivery capabilities and deep technical expertise to support our clients. The ABSL Diamond awards recognise companies that implement innovative projects, enhancing their business and strengthening the position of the business services sector. Every year, the aim is to identify successful activities in this sector and promote best practices, ultimately encouraging and inspiring others to follow suit. The ABSL celebrates initiatives that push business services forward and stand out as exemplary projects. Bill Padfield, Group Chief Operating Officer for Transformation and Services at Dimension Data, said: “Winning another award for our Support Services is a fantastic achievement. This time the ABSL Di
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme